This topic contains a solution. Click here to go to the answer

Author Question: Injection of anesthetic drugs into the dural sac surrounding axons of the cauda equina would be ... (Read 49 times)

jwb375

  • Hero Member
  • *****
  • Posts: 540
Injection of anesthetic drugs into the dural sac surrounding axons of the cauda equina would be expected to deaden pain sensation in the
 
  A) face.
  B) hands.
  C) pelvic region.
  D) middle chest.
  E) neck and upper chest.

Question 2

________ fibers send their information toward the brain.
 
  A) Afferent
  B) Efferent
  C) Projection
  D) Somatic
  E) Apolar



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Koolkid240

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

Answer: C

Injection of anesthetic drugs into the dural sac surrounding axons of the cauda equina would be expected to deaden pain sensation in the pelvic region.

Answer to Question 2

Answer: A




jwb375

  • Member
  • Posts: 540
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


dantucker

  • Member
  • Posts: 346
Reply 3 on: Yesterday
Excellent

 

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library